DekaBank Deutsche Girozentrale Has $7.91 Million Stock Holdings in Corteva, Inc. (NYSE:CTVA)

DekaBank Deutsche Girozentrale lowered its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 7.1% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 132,362 shares of the company's stock after selling 10,168 shares during the period. DekaBank Deutsche Girozentrale's holdings in Corteva were worth $7,910,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Sepio Capital LP grew its stake in Corteva by 3.2% in the fourth quarter. Sepio Capital LP now owns 5,361 shares of the company's stock worth $305,000 after purchasing an additional 166 shares during the period. Allred Capital Management LLC lifted its holdings in shares of Corteva by 3.2% during the fourth quarter. Allred Capital Management LLC now owns 5,447 shares of the company's stock valued at $310,000 after purchasing an additional 171 shares in the last quarter. NTV Asset Management LLC lifted its holdings in Corteva by 3.3% in the first quarter. NTV Asset Management LLC now owns 5,457 shares of the company's stock valued at $343,000 after acquiring an additional 173 shares during the period. Avantax Planning Partners Inc. lifted its holdings in Corteva by 4.1% in the first quarter. Avantax Planning Partners Inc. now owns 4,539 shares of the company's stock valued at $286,000 after acquiring an additional 178 shares during the period. Finally, PFG Investments LLC increased its position in Corteva by 1.4% in the first quarter. PFG Investments LLC now owns 12,867 shares of the company's stock worth $810,000 after buying an additional 180 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company's stock.

Corteva Stock Performance

Corteva stock traded down $1.05 on Tuesday, reaching $72.06. 5,717,540 shares of the stock were exchanged, compared to its average volume of 3,441,944. The firm has a fifty day moving average price of $71.66 and a two-hundred day moving average price of $64.81. The stock has a market cap of $49.16 billion, a PE ratio of 43.94, a PEG ratio of 1.88 and a beta of 0.76. The company has a current ratio of 1.44, a quick ratio of 1.00 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a twelve month low of $50.30 and a twelve month high of $77.41.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $1.13 EPS for the quarter, beating the consensus estimate of $0.88 by $0.25. Corteva had a net margin of 6.77% and a return on equity of 7.84%. The business had revenue of $4.42 billion for the quarter, compared to analysts' expectations of $4.56 billion. During the same period in the prior year, the firm earned $0.89 earnings per share. Corteva's revenue was down 1.7% compared to the same quarter last year. Sell-side analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Friday, May 2nd were paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.94%. The ex-dividend date was Monday, June 2nd. Corteva's dividend payout ratio (DPR) is 41.46%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CTVA. KeyCorp lifted their target price on Corteva from $72.00 to $84.00 and gave the stock an "overweight" rating in a report on Monday. UBS Group boosted their price target on Corteva from $76.00 to $90.00 and gave the stock a "buy" rating in a research report on Wednesday, July 9th. Royal Bank Of Canada upped their price target on Corteva from $74.00 to $85.00 and gave the stock an "outperform" rating in a report on Thursday, July 10th. Citigroup raised their price target on Corteva from $75.00 to $78.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. Finally, Wells Fargo & Company increased their price objective on Corteva from $79.00 to $82.00 and gave the company an "overweight" rating in a research note on Monday, June 23rd. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $77.38.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.